BERKELEY, Calif. (AP) _ Aduro Biotech Inc. (ADRO) on Thursday reported a loss of $18.6 million in its second quarter.
On a per-share basis, the Berkeley, California-based company said it had a loss of 23 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The drug developer posted revenue of $4.9 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $4.6 million.
The company's shares closed at $1.40. A year ago, they were trading at $5.40.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADRO at https://www.zacks.com/ap/ADRO
Automated Insights, source Associated Press News